Exact Sciences Corporation
EXAS
$103.75
-$0.19-0.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 17.69% | 14.47% | 12.56% | 11.57% | 10.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.69% | 14.47% | 12.56% | 11.57% | 10.37% |
| Cost of Revenue | 17.15% | 7.78% | 8.11% | 10.79% | 13.91% |
| Gross Profit | 17.93% | 17.70% | 14.61% | 11.91% | 8.88% |
| SG&A Expenses | 13.21% | 9.93% | 6.99% | 3.30% | 1.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.51% | 9.73% | 6.38% | 5.13% | 4.90% |
| Operating Income | 15.94% | 46.53% | 50.76% | 45.32% | 38.74% |
| Income Before Tax | 80.32% | -372.42% | -489.45% | -332.83% | -413.60% |
| Income Tax Expenses | 155.60% | -336.28% | -417.09% | -448.20% | -403.95% |
| Earnings from Continuing Operations | 79.79% | -360.94% | -474.39% | -324.54% | -403.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.79% | -360.94% | -474.39% | -324.54% | -403.97% |
| EBIT | 15.94% | 46.53% | 50.76% | 45.32% | 38.74% |
| EBITDA | 161.62% | 954.56% | 213.62% | 133.80% | 121.67% |
| EPS Basic | 80.14% | -353.69% | -464.23% | -315.26% | -390.03% |
| Normalized Basic EPS | 18.28% | 45.18% | 49.65% | 45.23% | 40.07% |
| EPS Diluted | 80.14% | -353.69% | -464.18% | -315.23% | -389.99% |
| Normalized Diluted EPS | 18.28% | 45.18% | 49.37% | 44.97% | 39.78% |
| Average Basic Shares Outstanding | 2.44% | 2.42% | 2.39% | 2.34% | 2.25% |
| Average Diluted Shares Outstanding | 2.44% | 2.42% | 1.91% | 1.85% | 1.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |